Clinical Trials
According to MeSH, a clinical trial is work that is the report of a pre-planned clinical study of the safety, efficacy, or optimum dosage schedule of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in humans selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects.
Progress in the treatment of cancer patients is usually based upon the results of clinical trials. The primary source for information on clinical trials is the federal database, Clinical Trials.gov. MMRF and IMF also link to trial information specific to multiple myeloma research.
Clinical Trials.gov
http://clinicaltrials.gov/search/open/condition=%22Multiple+Myeloma%22
ClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial’s purpose, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.
The MMRF maintains its own clinical trials site here: http://www.multiplemyeloma.org/clinical_trials/4.04.php
MMRF also offers a patient-trial matching system here: http://multiplemyeloma.org/clinical_trials/4.09.php
The IMF links to trials here: http://myeloma.org/main.jsp?source=tab&type=tab&tab_id=4
This site also provides summaries of the latest published research.
